Literature DB >> 15651088

Drug utilization statistics for individual-level pharmacy dispensing data.

Jesper Hallas1.   

Abstract

The emergence of large, computerized pharmacoepidemiologic databases has enabled us to study drug utilization with the individual user as the unit of analysis. A recurrent problem in such analyses, however, is the overwhelming volume and complexity of data. This paper reviews the methods to estimate basic epidemiologic measures of drug utilization and some methods to screen for aberrant prescribing patterns. It also presents the basis and application of the waiting time distributions that can provide information about the period prevalence, point prevalence, incidence, duration of use, seasonality and rate of prescription renewal or relapse for specific drugs. If analyzed regularly, these measures can disclose subtle trends in clinical drug use that would not be evident from the wholesale figures. In specific situations, pharmacy dispensing data without diagnostic information can be used to assess the association between drug use and adverse effects in a prescription symmetry design. Copyright 2005 John Wiley & Sons, Ltd.

Mesh:

Year:  2005        PMID: 15651088     DOI: 10.1002/pds.1063

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  25 in total

1.  Identification of asthmatic children using prescription data and diagnosis.

Authors:  Grete Moth; Peter Vedsted; Po Schiøtz
Journal:  Eur J Clin Pharmacol       Date:  2007-03-27       Impact factor: 2.953

2.  Driving forces behind increasing cardiovascular drug utilization: a dynamic pharmacoepidemiological model.

Authors:  Helle Wallach Kildemoes; Henrik Støvring; Morten Andersen
Journal:  Br J Clin Pharmacol       Date:  2008-12       Impact factor: 4.335

3.  On pharmaceutical risk minimization.

Authors:  Torbjörn Callréus
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

4.  Prevalence, incidence and persistence of anti-asthma medication use in 2- to 29-year-olds: a nationwide prescription study.

Authors:  Oystein Karlstad; Per Nafstad; Aage Tverdal; Svetlana Skurtveit; Kari Furu
Journal:  Eur J Clin Pharmacol       Date:  2009-11-21       Impact factor: 2.953

5.  Characteristics and drug utilization patterns for heavy users of prescription drugs among the elderly: a Danish register-based drug utilization study.

Authors:  Anita Øymoen; Anton Pottegård; Anna Birna Almarsdóttir
Journal:  Eur J Clin Pharmacol       Date:  2015-04-28       Impact factor: 2.953

6.  The use of a prescription drug monitoring program to develop algorithms to identify providers with unusual prescribing practices for controlled substances.

Authors:  Christopher Ringwalt; Sharon Schiro; Meghan Shanahan; Scott Proescholdbell; Harold Meder; Anna Austin; Nidhi Sachdeva
Journal:  J Prim Prev       Date:  2015-10

7.  Long-term risk of hip or forearm fractures in older occasional users of benzodiazepines.

Authors:  Hélène Carrier; Sébastien Cortaredona; Viviane Philipps; Hélène Jacqmin-Gadda; Marie Tournier; Hélène Verdoux; Pierre Verger
Journal:  Br J Clin Pharmacol       Date:  2020-05-10       Impact factor: 4.335

8.  Geographical differences in the prevalence of chronic polypharmacy in older people: eleven years of the EPIFARM-Elderly Project.

Authors:  Carlotta Franchi; Massimo Cartabia; Paolo Risso; Daniela Mari; Mauro Tettamanti; Alberto Parabiaghi; Luca Pasina; Codjo Djignefa Djade; Ida Fortino; Angela Bortolotti; Luca Merlino; Alessandro Nobili
Journal:  Eur J Clin Pharmacol       Date:  2013-03-28       Impact factor: 2.953

9.  The use and potential abuse of anticholinergic antiparkinson drugs in Norway: a pharmacoepidemiological study.

Authors:  Pål Gjerden; Jørgen G Bramness; Lars Slørdal
Journal:  Br J Clin Pharmacol       Date:  2008-12-16       Impact factor: 4.335

10.  Dispensed drugs and multiple medications in the Swedish population: an individual-based register study.

Authors:  Bo Hovstadius; Bengt Astrand; Göran Petersson
Journal:  BMC Clin Pharmacol       Date:  2009-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.